"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Descriptor ID |
D015996
|
MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 3 | 3 |
1996 | 0 | 4 | 4 |
1997 | 0 | 4 | 4 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 6 | 6 |
2002 | 0 | 3 | 3 |
2003 | 0 | 4 | 4 |
2004 | 0 | 5 | 5 |
2005 | 0 | 11 | 11 |
2006 | 0 | 4 | 4 |
2007 | 0 | 8 | 8 |
2008 | 0 | 12 | 12 |
2009 | 0 | 13 | 13 |
2010 | 0 | 19 | 19 |
2011 | 0 | 28 | 28 |
2012 | 0 | 22 | 22 |
2013 | 0 | 18 | 18 |
2014 | 0 | 14 | 14 |
2015 | 0 | 19 | 19 |
2016 | 0 | 26 | 26 |
2017 | 0 | 25 | 25 |
2018 | 0 | 26 | 26 |
2019 | 0 | 26 | 26 |
2020 | 0 | 17 | 17 |
2021 | 0 | 11 | 11 |
2022 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992.
-
CPR quality and outcomes after extracorporeal life support for pediatric In-Hospital cardiac arrest. Resuscitation. 2023 08; 189:109874.
-
Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023 May; 617(7961):599-607.
-
Leptomeningeal Metastases of the Spine: A Systematic Review. Anticancer Res. 2022 02; 42(2):619-628.
-
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108). J Clin Oncol. 2022 03 20; 40(9):978-987.
-
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2022 02; 164(2):398-405.
-
Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. World Neurosurg. 2022 01; 157:e245-e253.
-
The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study. World Neurosurg. 2022 01; 157:e123-e128.
-
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. JAMA Cardiol. 2021 09 01; 6(9):1032-1041.
-
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer. J Urol. 2022 01; 207(1):70-76.